COMP <GO>
NRC vs ISPC // EV/EBITDA & P/E VALUATION
NRC Health (NASDAQ) VS. iSpecimen Inc. (NASDAQ) • 15-METRIC TALLY: NRC 8
— ISPC 0
■ METRIC PARITY
LAST: $23.49 (+0.09%) • MKT CAP: $519.6M
valuation
18.6x
LAST: $0.79 (-9.35%) • MKT CAP: $2.0M
valuation
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (NRC VS. ISPC)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | NRC | ISPC | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 11.20% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 21.00% | -35.00% | +56.00 | NRC | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 18.6x | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 3.03% | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | 16.40% | -60.00% | +76.40 | NRC | /operating-margins <GO> |
| Net Profit Margin | 8.40% | -60.00% | +68.40 | NRC | /net-margins <GO> |
| Revenue Growth (YoY) | -4.00% | -65.00% | +61.00 | NRC | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 2.11% | 0.00% | +2.11 | NRC | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.82 | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 3/9 | +1.00 | NRC | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 66.7 | 31.0 | +35.65 | NRC | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 41.7x | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $519.6M | $2.0M | $517.6M | NRC | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | NRC REV | ISPC REV | NRC GROSS % | ISPC GROSS % | NRC FCF | ISPC FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $137.4M | $1.9M | — | 11.2% | $15.7M | -$4.2M |
| FY 2024 | $143.1M | $9.3M | — | 45.0% | $19.2M | -$8.3M |
| FY 2023 | $148.6M | $9.9M | — | — | $38.1M | -$5.8M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
NRC // BETA —
ISPC // BETA —